All News about Instil Bio, Inc.Via Talk Markets
Instil Bio Resumes ITIL-306 Study In Lung, Ovarian, Renal Cancers
January 09, 2023
Via Benzinga
Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split
December 05, 2023
From Instil Bio
Via GlobeNewswire
Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 13, 2023
From Instil Bio
Via GlobeNewswire
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 29, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
December 23, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|